Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Items 1–5 — Disease Prevention & Health Promotion
1) Reference
Ch. 1 — Disease Prevention & Health Promotion — Overview
Question Stem
A 58-year-old man with type 2 diabetes and stage 3 chronic
,kidney disease asks whether he should start the recombinant
zoster vaccine. Which factor most strongly supports offering the
vaccine now?
A. Age over 50 years
B. Active immunosuppressive therapy for rheumatoid arthritis
C. Prior history of varicella infection in childhood
D. Estimated glomerular filtration rate (eGFR) 45 mL/min/1.73
m²
Correct Answer: A
Rationales
• A (Correct): CMDT emphasizes age-based
recommendations for zoster vaccination (recombinant
zoster vaccine) — age ≥50 is a primary indication for
routine vaccination in immunocompetent adults, and
comorbidities like diabetes support vaccination to reduce
shingles risk. accessmedicine.mhmedical.com
• B (Incorrect): Active immunosuppressive therapy may
require specialist input and timing adjustments; it does not
by itself supersede the age indication. Vaccination decision
in immunosuppressed patients is nuanced.
accessmedicine.mhmedical.com
• C (Incorrect): Prior varicella (chickenpox) does not
contraindicate zoster vaccination; in fact, prior VZV
exposure is common and vaccination prevents
reactivation. accessmedicine.mhmedical.com
, • D (Incorrect): Moderate CKD alone (eGFR ~45) is not a
contraindication and is less determinative than age for
routine zoster vaccine recommendation.
accessmedicine.mhmedical.com
Teaching Point: Recommend recombinant zoster vaccine for
adults beginning at age ≥50 years.
Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
2) Reference
Ch. 1 — Disease Prevention & Health Promotion — Smoking
Cessation Counseling
Question Stem
A 46-year-old woman who smokes 1 pack/day is ambivalent
about quitting. According to prevention counseling principles in
CMDT, which is the most appropriate next step to enhance her
likelihood of quitting?
A. Provide brief advice to quit and schedule a follow-up in 1
month
B. Prescribe a nicotine patch immediately without counseling
C. Use motivational interviewing to explore ambivalence and
elicit change talk
D. Tell her that cessation will reduce cancer risk but avoid
discussing pharmacotherapy
, Correct Answer: C
Rationales
• C (Correct): CMDT highlights behavioral counseling
strategies (motivational interviewing) to increase readiness
to quit; addressing ambivalence is higher yield than advice
alone. celsus.com.co
• A (Incorrect): Brief advice is helpful but less effective alone
in ambivalent patients than structured motivational
approaches and planned follow-up. celsus.com.co
• B (Incorrect): Pharmacotherapy improves quit rates but is
most effective when combined with counseling;
prescribing without counseling misses a key component.
celsus.com.co
• D (Incorrect): Education about risks is necessary but
avoiding discussion of effective pharmacotherapy
decreases chances of successful cessation. celsus.com.co
Teaching Point: Combine motivational interviewing with
pharmacotherapy to maximize smoking cessation success.
Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
3) Reference